Thalassemia Conclave 2025 Unites Global Experts To Advance Care, Strengthen Policies, And Foster Collaborative Innovations

Thalassemia Conclave 2025 by Voice of Healthcare (VOH) at Le Meridien, New Delhi, hosted international healthcare leaders, policymakers, and patient activists to address the pressing need for improved Thalassemia care, early detection, and policy action. With more than 100,000 transfusion-dependent patients and 10,000–15,000 new cases every year in India, the conclave aimed to facilitate greater collaboration and best practices.

International invitees to the conference came from India, UAE, Maldives, Nepal, Bangladesh, Sri Lanka, and Pakistan. These included Her Highness Sheikha Sheikha Bint Saif (UAE), Dr. Androulla Eleftheriou (Thalassaemia International Federation), Mr. Deepak Chopra, Ms. Shobha Tuli, Dr. Naveen Nishchal (VOH), and key experts in IAP, FOGSI, ISBTI, and the Ministry of Coal.

Mr. Deepak Chopra opened the conclave with a focus on collective action with the theme of "Care, Cure, and Control" and the creation of a National Blood Bank & Clot Centre in Delhi. Ms. Shobha Tuli highlighted CSR efforts towards Thalassemia care and appreciated Coal India's efforts.

Also Read: Hip Replacement Surgery Restores Mobility And Quality Of Life For 100-Year-Old Man In New Delhi

Dr. Androulla Eleftheriou reiterated global solidarity to care and prevention, calling for gene-based therapies and commitment to UN Sustainable Development Goals. Her Highness Sheikha Sheikha Bint Saif acknowledged efforts together in the fight against Thalassemia, and Dr. Vinod K Paul (NITI Aayog) appreciated the developments of India in screenings and an imperative call for a national program for prevention.

The key panel discussions were regional connectivity, gene therapy, new therapies, and access to critical care. Dr. Sunil Bhat, Dr. Antonio Piga, and Dr. Mohan Kumar K Murugesan spoke regarding new therapies and policy solutions. The conclave also shed light on regulatory issues, patient voices, and the economic burden of Thalassemia.

The conference was finished with an unmet needs session, where issues of blood safety, screening tactics, and state initiatives such as Ayushman Bharat were brought up. The valedictory speeches by the eminent dignitaries laid pragmatic ideas for improving the treatment of Thalassemia.

The Thalassemia Conclave 2025 marked a milestone achievement in policy creation, innovation creation, and improvement of global partnership to build Thalassemia-free horizons.